medicina55巻10号

2018年09月発行

特集 クリティカル・ケアを極める—一歩進んだ総合内科医を目指して 内科クリティカル・ケア実践編─このパターンを押さえれば8割は対応可能

重症病態に合併する血小板減少のアプローチ

著者： 高岸勝繁¹

所属機関： ¹京都岡本記念病院総合診療科

ページ範囲：P.1590 - P.1595

Point
◎ICUにおける血小板減少では，敗血症や一過性侵襲による播種性血管内凝固症候群（DIC）として典型的かどうかに注目する．
◎典型的ではない場合は，治療が必要な病態を意識してチェックする．

参考文献

1）Hui P, et al：The frequency and clinical significance of thrombocytopenia complicating critical illness；A systematic review. Chest 139：271-278, 2011

2）Thiele T, et al：Thrombocytopenia in the intensive care unit-diagnostic approach and management. Semin Hematol 50：239-250, 2013

3）Zarychanski R, Houston DS：Assessing thrombocytopenia in the intensive care unit；The past, present, and future. Hematology Am Soc Hematol Educ Program 2017：660-666, 2017

4）François B, et al：Thrombocytopenia in the sepsis syndrome；Role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 103：114-120, 1997

5）Claushuis TA, et al：Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. Blood 127：3062-3072, 2016

6）Greinacher A, Selleng K：Thrombocytopenia in the intensive care unit patient. Hematology Am Soc Hematol Educ Program 2010：135-143, 2010

7）Kelton JG, et al：Nonheparin anticoagulants for heparin-induced thrombocytopenia. N Engl J Med 368：737-744, 2013

8）Warkentin TE, Heddle NM：Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2：148-157, 2003

9）Selleng K, et al：Heparin-induced thrombocytopenia in intensive care patients. Crit Care Med 35：1165-1176, 2007

10）Althaus K, et al：Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia. Thromb Res 131：e85-e90, 2013

11）Ishii E, et al：Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 86：58-65, 2007

12）Fardet L, et al：Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 66：2613-2620, 2014

13）Valade S, et al：Coagulation disorders and bleeding in critically ill patients with hemophagocytic lymphohistiocytosis. Medicine（Baltimore）94：e1692, 2015

14）Grangé S, et al：The use of ferritin to identify critically ill patients with secondary hemophagocytic lymphohistiocytosis. Crit Care Med 44：e1045-e1053, 2016

15）Demirkol D, et al：Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome；What is the treatment? Crit Care 16：R52, 2012

16）George JN, Nester CM：Syndromes of thrombotic microangiopathy. N Engl J Med 371：654-666, 2014

17）George JN：Clinical practice；Thrombotic thrombocytopenic purpura. N Engl J Med 354：1927-1935, 2006

18）Park YA, et al：Platelet count and prothrombin time help distinguish thrombotic thrombocytopenic purpura-hemolytic uremic syndrome from disseminated intravascular coagulation in adults. Am J Clin Pathol 133：460-465, 2010

19）Schapkaitz E, Mezgebe MH：The clinical significance of schistocytes；A prospective evaluation of the International Council for Standardization in Hematology schistocyte guidelines. Turk J Haematol 34：59-63, 2017

20）Huh HJ, et al：Microscopic schistocyte determination according to International Council for Standardization in Hematology recommendations in various diseases. Int J Lab Hematol 35：542-547, 2013

21）Lesesve JF, et al：Schistocytes in disseminated intravascular coagulation. Int J Lab Hematol 36：439-443, 2014

22）Moake JL：Thrombotic microangiopathies. N Engl J Med 347：589-600, 2002